Roche Holding Non-GAAP EPS of CHF 10.23, Revenue of CHF 29.85B; Raises FY24 Outlook
ASML Holding Declares €1.52 Interim Dividend
ASML Holding GAAP EPS of €4.01, Revenue of €6.2B; Initiates Q3 and Reaffirms FY24 Outlook
Reported Thursday, Roche's Genentech Halts SKYSCRAPER-06 Trial After Tiragolumab Plus Tecentriq And Chemotherapy Show Reduced Efficacy Compared To Comparator Arm
Roche's Genentech Receives FDA Approval For Vabysmo Prefilled Syringe (PFS) To Treat Three Leading Causes Of Vision Loss
Top 10 ETF Inflow Leaders for June - Citi Research
Vanguard FTSE Developed Markets ETF To Go Ex-Dividend On June 21st, 2024 With 0.4607 USD Dividend Per Share
Roche's VENTANA DP 200 Digital System Approved For Diagnostic Use By FDA
Reported Saturday, Genentech's Phase III STARGLO Study Shows Columvi Increases Survival For Patients With Relapsed Or Refractory Diffuse Large B-cell Lymphoma
Citi Says ETFs Will Engulf U.S. Asset Management Industry
ASML Climbing 7%, Planning Deal with Taiwan Semi
China's Trade With DM Has Reduced; Increased With EM - SG
Roche's Genentech Granted Priority Review By FDA For Inavolisib, An Investigational Oral Therapy, In Combination With Palbociclib (Ibrance) And Fulvestrant
Reported Earlier, Roche And Hitachi High-Tech Extend 46-Year Partnership For Diagnostic Testing Advances
Marjorie Taylor Greene Reveals New Stock Trades After 2-Year Gap: Berkshire Hathway, Goldman Sachs And Microsoft Make The List — But Trump's DJT Doesn't
Two Metrics Show Stocks Are Oversold Heading Into May - Blue Chip Daily Trend Report
ASML's Grim Earnings Spark Chip Stock Sell-off: What Are the Warning Signs?
Takes One Bad ASML To Spoil the Semis | Wall Street Today
National Debt Drama Deepens: Where To Stash Your Cash When The Fiscal Sky Falls
Smart Money Is Betting Big In ASML Options